Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (4,654) Arrow Down
Filter Results: (4,654) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (4,654)
    • People  (16)
    • News  (1,863)
    • Research  (2,240)
    • Events  (2)
    • Multimedia  (220)
  • Faculty Publications  (1,824)

Show Results For

  • All HBS Web  (4,654)
    • People  (16)
    • News  (1,863)
    • Research  (2,240)
    • Events  (2)
    • Multimedia  (220)
  • Faculty Publications  (1,824)
← Page 104 of 4,654 Results →

    Innovating in Healthcare: Creating Breakthrough Services, Products, and Business Models

    Innovating in Healthcare offers effective approaches for designing, reworking, and implementing innovative healthcare services, products, and business models. It will help anyone working in healthcare service or product development, from hospitals to... View Details

    • 05 Sep 2017
    • News

    Bargaining With Cancer Patients About Treatment

    • December 1998 (Revised September 1999)
    • Case

    Novartis: Betting on Life Sciences

    By: Ray A. Goldberg, Carin-Isabel Knoop and Srinivas Sunder
    The merger of Ciba-Geigy and Sandoz produced genomic-based synergies for health care, agribusiness, and nutritional supplements. How to build on the strength of the individual divisions and provide synergies that would continue Novartis' leadership role is the question... View Details
    Keywords: Mergers and Acquisitions; Business Divisions; Health Care and Treatment; Leadership; Product Positioning; Science-Based Business; Corporate Strategy; Pharmaceutical Industry
    Citation
    Educators
    Purchase
    Related
    Goldberg, Ray A., Carin-Isabel Knoop, and Srinivas Sunder. "Novartis: Betting on Life Sciences." Harvard Business School Case 599-076, December 1998. (Revised September 1999.)
    • 21 Apr 2009
    • First Look

    First Look: April 21, 2009

    distinguishing between direct and complementary spillovers, we examine (1) the extent to which a hospital's specialization in areas related to cardiovascular care directly impacts performance in cardiovascular View Details
    Keywords: Martha Lagace
    • March 2018 (Revised January 2019)
    • Case

    Gilead Mexico

    By: Michael Chu and V. Kasturi Rangan
    With a breakthrough cure for Hepatitis C listing in the U.S. at $1,000/pill, Gilead must now solve the issue of making it available to patients across the world, much as it did for its blockbuster HIV/AIDS antiretrovirals. For Erik Musalem, the new general manager of... View Details
    Keywords: Health Care and Treatment; Price; Strategy; Management; Pharmaceutical Industry; Mexico
    Citation
    Educators
    Purchase
    Related
    Chu, Michael, and V. Kasturi Rangan. "Gilead Mexico." Harvard Business School Case 318-111, March 2018. (Revised January 2019.)
    • Web

    Faculty & Research

    an early-withdrawal penalty of 1 . When households have heterogeneous present bias, the social optimum is well approximated by a two-account system: (i) an account that is completely liquid and (ii) an account that is completely illiquid until retirement. View Details
    • Article

    The Economic Consequences of Hospital Admissions

    By: Carlos Dobkin, Amy Finkelstein, Raymond Kluender and Matthew Notowidigdo
    We use an event study approach to examine the economic consequences of hospital admissions for adults in two datasets: survey data from the Health and Retirement Study, and hospitalization data linked to credit reports. For non-elderly adults with health insurance,... View Details
    Keywords: Personal Finance; Borrowing and Debt; Insurance; Insolvency and Bankruptcy; Health Care and Treatment
    Citation
    Find at Harvard
    Read Now
    Related
    Dobkin, Carlos, Amy Finkelstein, Raymond Kluender, and Matthew Notowidigdo. "The Economic Consequences of Hospital Admissions." American Economic Review 108, no. 2 (February 2018): 308–352.
    • 13 Apr 2017
    • News

    What Precision Medicine Can Learn from the NFL

    • 02 Sep 2014
    • First Look

    First Look: September 2

    legacy labor and health care costs-is seriously incomplete and that GM's share collapsed for many of the same reasons that many of the other highly successful American firms of the 50s, 60s, and 70s were... View Details
    Keywords: Sean Silverthorne
    • February 2018
    • Article

    Maintaining Beliefs in the Face of Negative News: The Moderating Role of Experience

    By: Bradley R. Staats, Diwas S. KC and F. Gino
    Many models in operations management involve dynamic decision making that assumes optimal updating in response to information revelation. However, behavioral theory suggests that rather than updating their beliefs, individuals may persevere in their prior beliefs. In... View Details
    Keywords: Information; Announcements; Service Operations; Decision Making; Medical Specialties; Experience and Expertise; Medical Devices and Supplies Industry
    Citation
    Find at Harvard
    Related
    Staats, Bradley R., Diwas S. KC, and F. Gino. "Maintaining Beliefs in the Face of Negative News: The Moderating Role of Experience." Management Science 64, no. 2 (February 2018): 804–824.
    • Web

    MS/MBA Biotechnology: Life Sciences | MBA

    and life science community include, the Harvard Business School (HBS) Health Care Initiative (HCI), HBS Blavatnik Fellowship in Life Science Entrepreneurship, the Harvard Biotech Club, the HBS View Details
    • 20 Jul 2021
    • News

    Rewriting the Social Contract

    • June 2001 (Revised May 2002)
    • Case

    Spir-It, Inc. (B): Managing People

    When Jack Sindler founded Spir-it, Inc. in 1934, he was the company's sole employee. By 1999, Sindler's firm more than survived its first 55 years. Employment was up to nearly 200, with facilities in two states and work done in three shifts. The product line--which had... View Details
    Keywords: Growth Management; Production; Business Growth and Maturation; Interpersonal Communication; Logistics; Human Resources; Diversity Characteristics; Manufacturing Industry
    Citation
    Educators
    Purchase
    Related
    Spear, Steven J. "Spir-It, Inc. (B): Managing People." Harvard Business School Case 601-091, June 2001. (Revised May 2002.)
    • Research Summary

    Fairness and Efficiency in Resource Allocation

    In studying the relationship of fairness and efficiency, Professor Trichakis takes the novel approach of looking at varied industries for unifying factors, and he pays special attention to inequities by incorporating both quantitative work in social welfare and the... View Details

      Alex Chan

      Keywords: health care
      • 22 Sep 2016
      • News

      The Road to Successful Bundled Payment Risk

      • 06 Nov 2013
      • News

      Six Ways to Save Obamacare

      • 08 Jun 2020
      • News

      Tenants and Investors Will Be Looking for Healthy Buildings

      • 29 Jan 2019
      • First Look

      New Research and Ideas, January 29, 2019

      generating consensus on the specifics of benefit-based taxation. Download working paper: https://www.hbs.edu/faculty/Pages/item.aspx?num=55548 Harvard Business School Case 818-017 Pricing PatientPing In 2017, Jay Desai, the CEO of Boston-based View Details
      Keywords: Dina Gerdeman
      • October 2022
      • Case

      Afrigen Biologics: Vaccines for the Global South

      By: Debora L. Spar and Julia Comeau
      The majority of vaccines used on the continent of Africa (99%) are produced offshore. This makes African nations reliant on the West for major health care needs, a problem which was exacerbated by the COVID-19 pandemic. Afrigen Biologics (in partnership with the WHO)... View Details
      Keywords: Vaccination; Vaccine; mRNA; COVID; COVID-19; Inequity; Hub-and-spoke; Health Care and Treatment; Health Pandemics; Production; Social Issues; Business and Government Relations; South Africa; Africa
      Citation
      Educators
      Purchase
      Related
      Spar, Debora L., and Julia Comeau. "Afrigen Biologics: Vaccines for the Global South." Harvard Business School Case 323-030, October 2022.
      • ←
      • 104
      • 105
      • …
      • 232
      • 233
      • →
      ǁ
      Campus Map
      Harvard Business School
      Soldiers Field
      Boston, MA 02163
      →Map & Directions
      →More Contact Information
      • Make a Gift
      • Site Map
      • Jobs
      • Harvard University
      • Trademarks
      • Policies
      • Accessibility
      • Digital Accessibility
      Copyright © President & Fellows of Harvard College.